Why would TTF be a competing treatment, if DCVax is being added to standard of care? Patients can still get TTF if they were to get DCVax, just as they did in the trial
Beyond that, I won’t comment on how you don’t mind some conflicts of interest as long as they agree with a long position. Address the actual concerns of the authors of those critiques, instead of looking for pathetic “gotcha” attempts.
I brought up that point before. I said he did not look into who were the critics and what possible conflicting reasons they could have. Danishdude did a deep dive into some of those critics and came up with a lot of confliction of interests, yet they had more weight in the article than the 73 peers.